Drug recall · January 22, 2025
glipiZIDE recall
Why: Failed Dissolution Specifications:
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
- Lots / codes
Lot # 1012910, Exp Date: 04/30/2025
- Quantity
- 2,028 units (cartons of 30 individual unit doses)
- Company
- Amerisource Health Services LLC, Columbus, OH
- Distribution
- Nationwide in the USA
- Initiated
- December 17, 2024 · Voluntary: Firm initiated
- Classified
- January 16, 2025
- Reported
- January 22, 2025
- Ended
- April 16, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glipizide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.